Arintra Secures $21 Million for Medical Coding Innovation

Medical coding platform Arintra has successfully secured $21 million in a Series A funding round led by Peak XV Partners, alongside contributions from Endeavor Health Ventures, Y Combinator, Counterpart Ventures, Spider Capital, Ten13, and various other strategic backers. This funding aims to enhance its adoption within U.S. health systems and physician groups, expedite product development, expand the team, and establish a new headquarters in the Bay Area.

The Vision Behind Arintra

Founded in 2020 by Nitesh Shroff and Preeti Bhargava, Arintra has created an autonomous medical coding platform that leverages GenAI technology for healthcare providers. Its innovative system automates the conversion of clinical documentation into precise insurance codes while also incorporating clinical documentation improvement (CDI) and denial prevention within one unified platform.

Transforming Healthcare Revenue Cycle Management

The core business model aims at allowing providers to obtain full, compliant reimbursements while lowering costs, enhancing claim accuracy, and speeding up cash flow. Arintra operates on an enterprise SaaS model that integrates with Electronic Health Record (EHR) systems, such as Epic and Athena, to seamlessly function within existing workflows.

Shroff, the CEO of Arintra, pointed out that the reimbursement process in healthcare is “fundamentally broken.” He noted that payers are rapidly adapting, employing policies and technologies that shift additional responsibilities onto providers, but that autonomous coding has not evolved at the same pace. Arintra was developed to assist healthcare providers in securing compliant revenue efficiently while alleviating challenges faced by frontline teams.

Target Market for Arintra

The firm’s strategic focus includes large health systems, hospitals, and physician groups, delivering measurable ROI through a robust revenue assurance approach.